PHS
BHC icon

PFM Health Sciences’s Bausch Health BHC Stock Holding History

PFM Health Sciences’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-196,511
Closed -$43.7M – 78
2015
Q2 		$43.7M Sell
196,511
-452,531
-70% -$100M 1.11% 38
2015
Q1 		$129M Sell
649,042
-611,591
-49% -$108M 3.55% 3
2014
Q4 		$180M Sell
1,260,633
-390,457
-24% -$52.5M 4.21% 3
2014
Q3 		$217M Buy
1,651,090
+608,680
+58% +$72.6M 4.99% 2
2014
Q2 		$131M Buy
1,042,410
+232,667
+29% +$29.7M 2.63% 13
2014
Q1 		$107M Buy
809,743
+747,595
+1,203% +$102M 1.94% 18
2013
Q4 		$7.3M Sell
62,148
-160
-0.3% -$17.5K 0.15% 57
2013
Q3 		$6.5M Sell
62,308
-226,769
-78% -$22.1M 0.16% 63
2013
Q2 		$24.9M Buy
+289,077
New +$22.8M 0.52% 43

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PFM Health Sciences's BHC Position: Q3 2015 in Review

PFM Health Sciences sold out of Bausch Health (BHC) in Q3 2015, closing a stake of 196,511 shares — an estimated $43.7M sold.

PFM Health Sciences first reported a position in BHC in Q2 2013 and held it in 9 quarters. The position peaked at $217M in Q3 2014. 546 funds tracked by Wall St. Rank hold BHC as of Q3 2015.

  • PFM Health Sciences reported no remaining Bausch Health position as of Q3 2015 after selling out during the quarter.
  • PFM Health Sciences sold 196,511 Bausch Health shares in Q3 2015, an estimated $43.7M.
  • PFM Health Sciences first reported a position in Bausch Health in Q2 2013 and held it in 9 quarters.
  • PFM Health Sciences's Bausch Health position peaked at $217M in Q3 2014.
  • 546 funds tracked by Wall St. Rank held Bausch Health as of Q3 2015.

Based on PFM Health Sciences's 13F filing for Q3 2015, filed 16 Nov 2015.